# Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation

> **NCT03244930** · PHASE2 · UNKNOWN · sponsor: **Hospital Universitario Dr. Jose E. Gonzalez** · enrollment: 20 (estimated)

## Conditions studied

- Lymphoma, Non-Hodgkin
- Lymphoma, Hodgkin
- Myeloma
- Stem Cell Transplant Complications

## Interventions

- **DRUG:** Plerixafor 0.12 mg/kg

## Key facts

- **NCT ID:** NCT03244930
- **Lead sponsor:** Hospital Universitario Dr. Jose E. Gonzalez
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-10
- **Primary completion:** 2018-05-10
- **Final completion:** 2018-06-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03244930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03244930, "Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03244930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*